Keywords: Infinity Pharma, Mundipharma, Purdue Pharma, PI3K, FAAH, Alliance, Equity investment

Infinity regains global rights to PI3K, FAAH; equity investment by Purdue

Article | 20 July 2012

USA-based Infinity Pharmaceuticals (Nasdaq: INFI) says it has restructured its strategic alliance with Swiss privately-held Mundipharma International and Purdue Pharmaceutical ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in